October 9 (SeeNews) - Croatian drug maker Pliva, a subsidiary of U.S. Barr Pharmaceuticals, has set the selling price of its non-core veterinary subsidiary Veterina at 100 kuna ($19.1/13.6euro) per share, the sale manager said on Tuesday.